AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
2 clinical trials · 2 recruiting · OTHER
Trials by AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
RECRUITINGPhase 1 / Phase 2NCT07053488
CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection
This early-phase clinical trial will assess the use of ex vivo CRISPR-Cas9 genome editing on donor liver grafts to reduce immunogenicity before transplantation. Donor livers will...
Sponsor: AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLCEnrolling: 901 location
Liver DiseasesLiver CancerLiver Cirrhosis+4
RECRUITINGPhase 1 / Phase 2NCT07053462
CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk
This clinical trial investigates the transplantation of donor kidneys that have been genetically modified ex vivo using CRISPR-Cas9 genome editing to reduce immunogenicity and...
Sponsor: AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLCEnrolling: 901 location
End-Stage Renal DiseaseEnd Stage Renal Disease on DialysisEnd Stage Renal Disease With Renal Transplant+4